When the efficacy of anti-VEGF monotherapy is undesirable,[28] combined dexamethasone intravitreal implant can be taken into consideration owing to the fact that the occurrence of macular edema is bound up with inflammatory response, which may improve the prognosis of patients.[29]. Here, VEGFA is linked to macular retinal edema.